Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

Item

http://www.wikidata.org/entity/Q36583683

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

@ast

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

@en

type

Item

label

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

@ast

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

@en

prefLabel

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

@ast

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

@en

P1476

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

@en

P2093

Aamir Akram

http://www.w3.org/2001/XMLSchema#string

David J Maloney

http://www.w3.org/2001/XMLSchema#string

Ganesha Rai

http://www.w3.org/2001/XMLSchema#string

Gary T Pauly

http://www.w3.org/2001/XMLSchema#string

Joel T Schneider

http://www.w3.org/2001/XMLSchema#string

Stephen H Hughes

http://www.w3.org/2001/XMLSchema#string

Steven J Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids

The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance

High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.

Crystal Structure of tert -Butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in Complex with HIV-1 Reverse Transcriptase (RT) Redefines the Elastic Limits of the Non-nucleoside Inhibitor-Binding Pocket

A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants

HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors

Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms

Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

P2888

s12977-016-0244-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12977-016-0244-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zandrea Ambrose

Kevin Melody

Craig J Thomas

P577

2016-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294738932

http://www.w3.org/2001/XMLSchema#string

P6179

1039530207

http://www.w3.org/2001/XMLSchema#string

P698

26880034

http://www.w3.org/2001/XMLSchema#string

P932

4754833

http://www.w3.org/2001/XMLSchema#string